A citation-based method for searching scientific literature

Camille Bigenwald, Jessica Le Berichel, C Matthias Wilk, Rikhia Chakraborty, Steven T Chen, Alexandra Tabachnikova, Rebecca Mancusi, Harshal Abhyankar, Maria Casanova-Acebes, Ilaria Laface, Guray Akturk, Jenielle Jobson, Zoi Karoulia, Jerome C Martin, John Grout, Anahita Rafiei, Howard Lin, Markus G Manz, Alessia Baccarini, Poulikos I Poulikakos, Brian D Brown, Sacha Gnjatic, Amaia Lujambio, Kenneth L McClain, Jennifer Picarsic, Carl E Allen, Miriam Merad. Nat Med 2021
Times Cited: 5







List of co-cited articles
21 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
Shabir A Madhi, Vicky Baillie, Clare L Cutland, Merryn Voysey, Anthonet L Koen, Lee Fairlie, Sherman D Padayachee, Keertan Dheda, Shaun L Barnabas, Qasim E Bhorat,[...]. N Engl J Med 2021
372
40

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.
Constantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, Mashudu Madzivhandila, Prudence Kgagudi, Brent Oosthuysen, Bronwen E Lambson, Tulio de Oliveira, Marion Vermeulen, Karin van der Berg,[...]. Nat Med 2021
470
40

Herd immunity by infection is not an option.
Devi Sridhar, Deepti Gurdasani. Science 2021
18
40

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
Florian Krammer, Komal Srivastava, Hala Alshammary, Angela A Amoako, Mahmoud H Awawda, Katherine F Beach, Maria C Bermúdez-González, Dominika A Bielak, Juan M Carreño, Rachel L Chernet,[...]. N Engl J Med 2021
234
40

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.
Rita E Chen, Xianwen Zhang, James Brett Case, Emma S Winkler, Yang Liu, Laura A VanBlargan, Jianying Liu, John M Errico, Xuping Xie, Naveenchandra Suryadevara,[...]. Nat Med 2021
293
40

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
Vivek Shinde, Sutika Bhikha, Zaheer Hoosain, Moherndran Archary, Qasim Bhorat, Lee Fairlie, Umesh Lalloo, Mduduzi S L Masilela, Dhayendre Moodley, Sherika Hanley,[...]. N Engl J Med 2021
143
40

Efficacy of MEK inhibition in patients with histiocytic neoplasms.
Eli L Diamond, Benjamin H Durham, Gary A Ulaner, Esther Drill, Justin Buthorn, Michelle Ki, Lillian Bitner, Hana Cho, Robert J Young, Jasmine H Francis,[...]. Nature 2019
90
40

RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.
Brandon Hogstad, Marie-Luise Berres, Rikhia Chakraborty, Jun Tang, Camille Bigenwald, Madhavika Serasinghe, Karen Phaik Har Lim, Howard Lin, Tsz-Kwong Man, Romain Remark,[...]. J Exp Med 2018
28
40

Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition.
Olive S Eckstein, Johannes Visser, Carlos Rodriguez-Galindo, Carl E Allen. Blood 2019
29
40

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.
Marie-Luise Berres, Karen Phaik Har Lim, Tricia Peters, Jeremy Price, Hitoshi Takizawa, Hélène Salmon, Juliana Idoyaga, Albert Ruzo, Philip J Lupo, M John Hicks,[...]. J Exp Med 2014
215
40

Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis.
Florian Halbritter, Matthias Farlik, Raphaela Schwentner, Gunhild Jug, Nikolaus Fortelny, Thomas Schnöller, Hanja Pisa, Linda C Schuster, Andrea Reinprecht, Thomas Czech,[...]. Cancer Discov 2019
23
40

Langerhans-Cell Histiocytosis.
Carl E Allen, Miriam Merad, Kenneth L McClain. N Engl J Med 2018
132
40

Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study.
Jean Donadieu, Islam Amine Larabi, Mathilde Tardieu, Johannes Visser, Caroline Hutter, Elena Sieni, Nabil Kabbara, Mohamed Barkaoui, Jean Miron, François Chalard,[...]. J Clin Oncol 2019
46
40

Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.
Benjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, David Abramson, Veronica Rotemberg, Steven De Munck, Erwin Pannecoucke, Sydney X Lu, Alessandro Pastore, Akihide Yoshimi,[...]. Nat Med 2019
44
40

Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.
Sofia Garces, L Jeffrey Medeiros, Keyur P Patel, Shaoying Li, Sergio Pina-Oviedo, Jingyi Li, Juan C Garces, Joseph D Khoury, C Cameron Yin. Mod Pathol 2017
79
40


Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.
Eli L Diamond, Benjamin H Durham, Julien Haroche, Zhan Yao, Jing Ma, Sameer A Parikh, Zhaoming Wang, John Choi, Eunhee Kim, Fleur Cohen-Aubart,[...]. Cancer Discov 2016
209
40

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.
Jean-François Emile, Oussama Abla, Sylvie Fraitag, Annacarin Horne, Julien Haroche, Jean Donadieu, Luis Requena-Caballero, Michael B Jordan, Omar Abdel-Wahab, Carl E Allen,[...]. Blood 2016
503
40

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.
Oussama Abla, Eric Jacobsen, Jennifer Picarsic, Zdenka Krenova, Ronald Jaffe, Jean-Francois Emile, Benjamin H Durham, Jorge Braier, Frédéric Charlotte, Jean Donadieu,[...]. Blood 2018
124
40


Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome.
Irina Maric, Stefania Pittaluga, Janet K Dale, Julie E Niemela, Georges Delsol, Judith Diment, Juan Rosai, Mark Raffeld, Jennifer M Puck, Stephen E Straus,[...]. Am J Surg Pathol 2005
79
40

T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study.
Chris Ka Pun Mok, Airu Zhu, Jingxian Zhao, Eric H Y Lau, Junxiang Wang, Zhao Chen, Zhen Zhuang, Yanqun Wang, Abeer N Alshukairi, Salim A Baharoon,[...]. Lancet Infect Dis 2021
20
20

Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Jianmin Zuo, Alexander C Dowell, Hayden Pearce, Kriti Verma, Heather M Long, Jusnara Begum, Felicity Aiano, Zahin Amin-Chowdhury, Katja Hoschler, Tim Brooks,[...]. Nat Immunol 2021
7
20

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome.
Katharina Röltgen, Abigail E Powell, Oliver F Wirz, Bryan A Stevens, Catherine A Hogan, Javaria Najeeb, Molly Hunter, Hannah Wang, Malaya K Sahoo, ChunHong Huang,[...]. Sci Immunol 2020
141
20

Sixteen novel lineages of SARS-CoV-2 in South Africa.
Houriiyah Tegally, Eduan Wilkinson, Richard J Lessells, Jennifer Giandhari, Sureshnee Pillay, Nokukhanya Msomi, Koleka Mlisana, Jinal N Bhiman, Anne von Gottberg, Sibongile Walaza,[...]. Nat Med 2021
122
20

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Jennifer M Dan, Jose Mateus, Yu Kato, Kathryn M Hastie, Esther Dawen Yu, Caterina E Faliti, Alba Grifoni, Sydney I Ramirez, Sonya Haupt, April Frazier,[...]. Science 2021
717
20

Toward superhuman SARS-CoV-2 immunity?
Dennis R Burton, Eric J Topol. Nat Med 2021
8
20

Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study.
Fang Tang, Yan Quan, Zhong-Tao Xin, Jens Wrammert, Mai-Juan Ma, Hui Lv, Tian-Bao Wang, Hong Yang, Jan H Richardus, Wei Liu,[...]. J Immunol 2011
266
20

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models.
David S Khoury, Adam K Wheatley, Mitchell D Ramuta, Arnold Reynaldi, Deborah Cromer, Kanta Subbarao, David H O'Connor, Stephen J Kent, Miles P Davenport. Nat Rev Immunol 2020
30
20

Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development.
Matthew J Memoli, Alison Han, Kathie-Anne Walters, Lindsay Czajkowski, Susan Reed, Rani Athota, Luz Angela Rosas, Adriana Cervantes-Medina, Jae-Keun Park, David M Morens,[...]. Clin Infect Dis 2020
19
20

Duration of humoral immunity to common viral and vaccine antigens.
Ian J Amanna, Nichole E Carlson, Mark K Slifka. N Engl J Med 2007
699
20

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Edson D Moreira, Cristiano Zerbini,[...]. N Engl J Med 2020
20

Neutralizing Activity of BNT162b2-Elicited Serum - Preliminary Report.
Yang Liu, Jianying Liu, Hongjie Xia, Xianwen Zhang, Camila R Fontes-Garfias, Kena A Swanson, Hui Cai, Ritu Sarkar, Wei Chen, Mark Cutler,[...]. N Engl J Med 2021
178
20

Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs.
Andrea J Wolf, Ludovic Desvignes, Beth Linas, Niaz Banaiee, Toshiki Tamura, Kiyoshi Takatsu, Joel D Ernst. J Exp Med 2008
366
20

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
Romina Libster, Gonzalo Pérez Marc, Diego Wappner, Silvina Coviello, Alejandra Bianchi, Virginia Braem, Ignacio Esteban, Mauricio T Caballero, Cristian Wood, Mabel Berrueta,[...]. N Engl J Med 2021
320
20

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study.
Edward E Walsh, Robert Frenck, Ann R Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Mark J Mulligan, Ruth Bailey,[...]. medRxiv 2020
70
20

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
Yanjun Zhang, Gang Zeng, Hongxing Pan, Changgui Li, Yaling Hu, Kai Chu, Weixiao Han, Zhen Chen, Rong Tang, Weidong Yin,[...]. Lancet Infect Dis 2021
358
20

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Katharine H D Crawford, Adam S Dingens, Rachel Eguia, Caitlin R Wolf, Naomi Wilcox, Jennifer K Logue, Kiel Shuey, Amanda M Casto, Brooke Fiala, Samuel Wrenn,[...]. J Infect Dis 2021
85
20

SARS-CoV-2 vaccines in development.
Florian Krammer. Nature 2020
601
20

Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15.
Jill M Ferdinands, Alicia M Fry, Sue Reynolds, Joshua Petrie, Brendan Flannery, Michael L Jackson, Edward A Belongia. Clin Infect Dis 2017
107
20

The establishment of resident memory B cells in the lung requires local antigen encounter.
S Rameeza Allie, John E Bradley, Uma Mudunuru, Michael D Schultz, Beth A Graf, Frances E Lund, Troy D Randall. Nat Immunol 2019
94
20

Herd Immunity: Understanding COVID-19.
Haley E Randolph, Luis B Barreiro. Immunity 2020
283
20

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
Aurélien Sokal, Pascal Chappert, Giovanna Barba-Spaeth, Anais Roeser, Slim Fourati, Imane Azzaoui, Alexis Vandenberghe, Ignacio Fernandez, Annalisa Meola, Magali Bouvier-Alias,[...]. Cell 2021
57
20

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.
Jeffrey Seow, Carl Graham, Blair Merrick, Sam Acors, Suzanne Pickering, Kathryn J A Steel, Oliver Hemmings, Aoife O'Byrne, Neophytos Kouphou, Rui Pedro Galao,[...]. Nat Microbiol 2020
463
20

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
Peter Chen, Ajay Nirula, Barry Heller, Robert L Gottlieb, Joseph Boscia, Jason Morris, Gregory Huhn, Jose Cardona, Bharat Mocherla, Valentina Stosor,[...]. N Engl J Med 2021
499
20

Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.
Jennifer A Juno, Hyon-Xhi Tan, Wen Shi Lee, Arnold Reynaldi, Hannah G Kelly, Kathleen Wragg, Robyn Esterbauer, Helen E Kent, C Jane Batten, Francesca L Mordant,[...]. Nat Med 2020
162
20

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Jerald Sadoff, Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev, Beatriz Grinsztejn, Paul A Goepfert, Carla Truyers, Hein Fennema, Bart Spiessens,[...]. N Engl J Med 2021
372
20

Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.
Alexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, Sarah R Leist, Melissa Cipolla, Stylianos Bournazos, Fabian Schmidt, Rachel M Maison, Anna Gazumyan, David R Martinez,[...]. J Exp Med 2021
121
20

Immunological characteristics govern the transition of COVID-19 to endemicity.
Jennie S Lavine, Ottar N Bjornstad, Rustom Antia. Science 2021
103
20

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Pedro M Folegatti, Katie J Ewer, Parvinder K Aley, Brian Angus, Stephan Becker, Sandra Belij-Rammerstorfer, Duncan Bellamy, Sagida Bibi, Mustapha Bittaye, Elizabeth A Clutterbuck,[...]. Lancet 2020
909
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.